PHIL 2805 Lecture Notes - Lecture 9: Syringe, Regulatory Agency, Drug Interaction
6 Jan 2021
School
Department
Course
Professor
Document Summary
Phil 2805 - lecture 9 october 6, 2020 disclosure tough cases. Suppose a health care professional dr. g used the reasonable standard approach and only informed the patient the information that dr. g deemed important and the patient understood it entirely. Limits of informed consent (o"neill: disclosing off-label prescriptions (wilkes and johns) It is a familiar and ethically important aspect of everyday transactions (o"neill, 4). Kantian wants a lot more in making decisions that has considered deep reflection of your values (deep autonomy). When you offer consent, you offer it to another party. This particular party is the person receiving the special permission so another person cannot substitute that party even though the action being provided is the same. The patient should be asked, are there easy ways for you to rescind their consent is this clear and straightforward for them to refuse consent. Basic ethical requirements: for all treatments offered by physicians:
